Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00534430 · OUTCOME

Overall Survival at 5 Years Post-Transplant.

Busulfan, Etoposide, and Total-Body Irradiation in Treating Patients Undergoing Donor Stem Cell or Bone Marrow Transplant for Advanced Hematologic Cancer · Source last updated 2026-06-03

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
percentage of survival probability
Interval / dispersion
95% Confidence Interval
Time frame
Date of Transplant to Five Years post-Transplant

What was measured

Kaplan-Meier estimate of an event of death estimated at five years post-transplant. 95% confidence intervals were calculated from the logit transform of the Greenwood variance. The transformation was necessary to keep the estimate within the probability space of 0 to 100%.

Analysis population: The Full Study Population

Groups in this outcome

Busulfan, FTBI and VP16

IV Busulfan + 12 cGy FTBI + VP16 prior to allogeneic Bone Marrow Transplant busulfan cyclosporine etoposide mycophenolate mofetil allogeneic bone marrow transplantation allogeneic hematopoietic stem cell transplantation peripheral blood stem cell transplantation total-body irradiation

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Busulfan, FTBI and VP1630

Reported measurements

Source class 1
Values in percentage of survival probability · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Busulfan, FTBI and VP1640Not reported2357Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        23
        upper Limit
        57
        value
        40
denoms
  1. counts
    1. group Id
      OG000
      value
      30
    units
    Participants
description
Kaplan-Meier estimate of an event of death estimated at five years post-transplant. 95% confidence intervals were calculated from the logit transform of the Greenwood variance. The transformation was necessary to keep the estimate within the probability space of 0 to 100%.
dispersion Type
95% Confidence Interval
groups
  1. description
    IV Busulfan + 12 cGy FTBI + VP16 prior to allogeneic Bone Marrow Transplant busulfan cyclosporine etoposide mycophenolate mofetil allogeneic bone marrow transplantation allogeneic hematopoietic stem cell transplantation peripheral blood stem cell transplantation total-body irradiation
    id
    OG000
    title
    Busulfan, FTBI and VP16
param Type
NUMBER
population Description
The Full Study Population
reporting Status
POSTED
time Frame
Date of Transplant to Five Years post-Transplant
title
Overall Survival at 5 Years Post-Transplant.
type
PRIMARY
unit Of Measure
percentage of survival probability

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice